Your browser doesn't support javascript.
loading
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
J Bone Miner Res ; 24(4): 578-88, 2009 Apr.
Article in En | MEDLINE | ID: mdl-19049336

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis / Bone and Bones / Genetic Markers / Osteoporosis, Postmenopausal / Bone Morphogenetic Proteins / Antibodies, Monoclonal Limits: Animals / Female / Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2009 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis / Bone and Bones / Genetic Markers / Osteoporosis, Postmenopausal / Bone Morphogenetic Proteins / Antibodies, Monoclonal Limits: Animals / Female / Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2009 Type: Article Affiliation country: United States